Recep Demirbag1, Remzi Yilmaz, Ozcan Erel. 1. Harran University, Faculty of Medicine, Department of Cardiology, Sanliurfa, Turkey. rdemirbag@yahoo.com
Abstract
OBJECTIVE: Although sex hormones have potential cardioprotective effects, their effects on total antioxidant capacity (TAC) are not very well known. The aim of the study was to evaluate TAC in men who have decreased and normal testosterone levels and in women in menopausal and premenopausal period. DESIGN: Ninety-seven subjects with similar age intervals, men aged <45 years and female aged <50 years, were divided into four groups: 1) 10 men with normal testosterone levels, as control, 2) 36 men with decreased testosterone, 3) 19 women in menopause, surgically induced, and 4) 32 women in premenopausal period. Testosterone and estrogen levels were measured by chemiluminescence assay and TAC were measured by using a more recently developed automated measurement method. RESULTS: The TAC was significantly lower in Group 2 and Group 3 than those of Group 1 and Group 4 (ANOVA, p<0.001). A strong correlation between TAC, and testosterone and estrogen were found (r=0.807, p<0.001; r=0.685, p<0.001, testosterone and estrogen respectively). CONCLUSIONS: The observed relationship between sex hormones and TAC may have a role in mechanism of their cardioprotective effect.
OBJECTIVE: Although sex hormones have potential cardioprotective effects, their effects on total antioxidant capacity (TAC) are not very well known. The aim of the study was to evaluate TAC in men who have decreased and normal testosterone levels and in women in menopausal and premenopausal period. DESIGN: Ninety-seven subjects with similar age intervals, men aged <45 years and female aged <50 years, were divided into four groups: 1) 10 men with normal testosterone levels, as control, 2) 36 men with decreased testosterone, 3) 19 women in menopause, surgically induced, and 4) 32 women in premenopausal period. Testosterone and estrogen levels were measured by chemiluminescence assay and TAC were measured by using a more recently developed automated measurement method. RESULTS: The TAC was significantly lower in Group 2 and Group 3 than those of Group 1 and Group 4 (ANOVA, p<0.001). A strong correlation between TAC, and testosterone and estrogen were found (r=0.807, p<0.001; r=0.685, p<0.001, testosterone and estrogen respectively). CONCLUSIONS: The observed relationship between sex hormones and TAC may have a role in mechanism of their cardioprotective effect.
Authors: A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi Journal: J Endocrinol Invest Date: 2010-06 Impact factor: 4.256
Authors: M Maggio; G P Ceda; F Lauretani; C Cattabiani; E Avantaggiato; S Morganti; F Ablondi; S Bandinelli; L J Dominguez; M Barbagallo; G Paolisso; R D Semba; L Ferrucci Journal: Int J Androl Date: 2011-06-15
Authors: George Paltoglou; Alexandra Avloniti; Athanasios Chatzinikolaou; Charikleia Stefanaki; Maria Papagianni; Ioannis Papassotiriou; Ioannis G Fatouros; George P Chrousos; Christina Kanaka-Gantenbein; George Mastorakos Journal: Endocrine Date: 2019-08-04 Impact factor: 3.633
Authors: G Kapuku; F Treiber; F Raouane; J Halbert; H Davis; S Young-Mayes; V Robinson; G Harshfield Journal: J Hum Hypertens Date: 2016-06-16 Impact factor: 3.012